LOTREXON

Pharmaceutical preparations and substances that are used alone or in combination with other pharmaceuticals, preparations or substances, and that act on the nervous system; pharmaceutical preparations and substances that that are used alone or in combination with other pharmaceuticals, preparations or substances, and have immunomodulatory activity; pharmaceutical preparations and substances that that are used alone or in combination with other pharmaceuticals, preparations or substances, and have anti-inflammatory activity; pharmaceutical preparations and substances that that are used alone or in combination with other pharmaceuticals, preparations or substances, and have hematopoietic lineage differentiation activity; pharmaceutical preparations and substances that are used alone or in combination with other pharmaceuticals, preparations or substances, and that act on various G protein-coupled receptors; pharmaceutical preparations and substances that are used alone or in combination with other pharmaceuticals, preparations or substances, and that act on non-GPCRs, including Toll-like receptors and p receptors; pharmaceutical preparations and substances that are used alone or in combination with other pharmaceuticals, preparations or substances, for the prevention and treatment of gastrointestinal, neurological, immunological, oncological and/or viral diseases and disorders